Yahoo Canada Web Search

Search results

    • Phio Pharmaceuticals Announces Reverse Stock Split

      Fairview Post· 5 days ago

      (Nasdaq: PHIO) (the “Company”), a clinical stage biotechnology company whose... gene silencing technology is designed to make immune cells more effective in killing tumor cells, today ...

    • Friday’s analyst upgrades and downgrades

      Friday’s analyst upgrades and downgrades

      The Globe and Mail· 3 days ago

      Canaccord Genuity analyst Luke Hannan reiterated a “buy” rating and increased his target price on Aritzia Inc. (ATZ-T) to $42 from $40 ahead of the...